ID   MOC-L1
AC   CVCL_A9X3
SY   Mouse Oral Carcinoma-Line 1
DR   BCRC; 60616
DR   Wikidata; Q102114547
RX   PubMed=30922255;
CC   Characteristics: Tumorigenic in syngeneic mice and also possesses a competence for neck dissemination.
CC   Doubling time: 24.7 hours (PubMed=30922255).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Thr122Asn (c.365_366CG>AT); Zygosity=Unspecified (PubMed=30922255).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:2676887; Mir211.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6 K14-EGFP-miR-211 transgenic.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
RX   PubMed=30922255; DOI=10.1186/s12885-019-5486-7; PMCID=PMC6440159;
RA   Chen Y.-F., Liu C.-J., Lin L.-H., Chou C.-H., Yeh L.-Y., Lin S.-C.,
RA   Chang K.-W.;
RT   "Establishing of mouse oral carcinoma cell lines derived from
RT   transgenic mice and their use as syngeneic tumorigenesis models.";
RL   BMC Cancer 19:281.1-281.11(2019).
//